(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis
Open Access
- 1 January 1980
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 17 (1), 8-12
- https://doi.org/10.1128/aac.17.1.8
Abstract
IDU (5-iodo-2'-deoxyuridine), BVDU [(E)-5-(2-bromovinyl)-2'-deoxyuridine] and placebo ointments were studied for their effects on experimental herpes simplex (type 1) keratoconjuncitivitis in rabbits. When treatment was begun 65 h after virus inoculation, both BVDU and IDU prevented development of keratitis. Both BVDU and IDU were also effective in suppressing the severity of conjunctivitis, and in this respect, BVDU proved significantly better than IDU. When treatment was started 110 h after virus inoculation, BVDU proved significantly better than IDU in promoting healing of established keratitis.This publication has 8 references indexed in Scilit:
- Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude miceAntimicrobial Agents and Chemotherapy, 1979
- (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.Proceedings of the National Academy of Sciences, 1979
- EFFICACY OF ACYCLOGUANOSINE (WELLCOME 248U) AGAINST HERPES-SIMPLEX CORNEAL ULCERSThe Lancet, 1979
- Effect of 9-(2-Hydroxyethoxymethyl)guanine on Herpesvirus-Induced Keratitis and Iritis in RabbitsAntimicrobial Agents and Chemotherapy, 1978
- Acyclic Antimetabolite Therapy of Experimental Herpes Simplex KeratitisAmerican Journal of Ophthalmology, 1978
- Phosphonoacetic Acid in the Treatment of Experimental Ocular Herpes Simplex InfectionsAntimicrobial Agents and Chemotherapy, 1976
- Therapeutic Antiviral Action of 5-Trifluoromethyl-2′-deoxyuridine in Herpes Simplex KeratitisScience, 1964
- Clinical Cure of Herpes Simplex Keratitis by 5-Iodo-2'-DeoxyuridineExperimental Biology and Medicine, 1962